CLEVELAND, July 28, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced it will host a conference call today at 4:30 PM (Eastern Time) to review the top-line data results of the phase I clinical trial of MultiStem®, its cell therapy treatment for individuals following AMI (or heart attack).
